Biotechnology in Asia-Pacific
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The Asia-Pacific biotechnology market recorded revenues of $313.5 billion in 2024, representing a compound annual growth rate (CAGR) of 11.4% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $166.6 billion, equivalent to 53.1% of the market's overall value.
- In 2024, the Asia-Pacific biotechnology market recorded an annual growth of 6.5%. The growth is attributed to the expanding international collaborations and investments in the market.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts by both value and volume
- What was the size of the Asia-Pacific biotechnology market by value in 2024?
- What will be the size of the Asia-Pacific biotechnology market in 2029?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the key players?
- 7.2. What strategies do the key players follow?
- 7.3. What have been the most recent market developments?
- 8 Company Profiles
- 8.1. Takeda Pharmaceutical Co Ltd
- 8.2. Astellas Pharma Inc
- 8.3. BeiGene Ltd
- 8.4. Kyowa Kirin Co Ltd
- 8.5. Chugai Pharmaceutical Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific biotechnology industry value: $ million, 2019-24
- Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2019-24
- Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2019-24
- Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2024
- Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2024-29
- Table 6: Takeda Pharmaceutical Co Ltd: Key Facts
- Table 7: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 8: Takeda Pharmaceutical Co Ltd: Key Employees
- Table 9: Astellas Pharma Inc: Key Facts
- Table 10: Astellas Pharma Inc: Annual Financial Ratios
- Table 11: Astellas Pharma Inc: Key Employees
- Table 12: BeiGene Ltd: Key Facts
- Table 13: BeiGene Ltd: Annual Financial Ratios
- Table 14: BeiGene Ltd: Key Employees
- Table 15: BeiGene Ltd: Key Employees Continued
- Table 16: Kyowa Kirin Co Ltd: Key Facts
- Table 17: Kyowa Kirin Co Ltd: Annual Financial Ratios
- Table 18: Kyowa Kirin Co Ltd: Key Employees
- Table 19: Kyowa Kirin Co Ltd: Key Employees Continued
- Table 20: Chugai Pharmaceutical Co Ltd: Key Facts
- Table 21: Chugai Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 22: Chugai Pharmaceutical Co Ltd: Key Employees
- Table 23: Asia-Pacific Exchange Rate, 2019-24
- List of Figures
- Figure 1: Asia-Pacific biotechnology industry value: $ million, 2019-24
- Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2019-24
- Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2024
- Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2024
- Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2024
- Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2024
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2024
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook